Home4TO • FRA
add
Mainz Biomed NV
Previous close
€0.20
Year range
€8.00 - €8.42
Market cap
6.27M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 125.18K | -32.92% |
Operating expense | 2.80M | -37.31% |
Net income | -3.93M | 25.61% |
Net profit margin | -3.14K | -10.89% |
Earnings per share | — | — |
EBITDA | -2.57M | 39.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 889.09K | -85.74% |
Total assets | 5.33M | -60.54% |
Total liabilities | 4.69M | -37.55% |
Total equity | 641.60K | — |
Shares outstanding | 12.52M | — |
Price to book | 2.86 | — |
Return on assets | -126.88% | — |
Return on capital | -210.37% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.93M | 25.61% |
Cash from operations | -2.23M | 51.40% |
Cash from investing | -291.14K | -362.47% |
Cash from financing | 2.04M | -71.29% |
Net change in cash | -510.99K | -119.44% |
Free cash flow | -1.32M | 50.79% |
About
Founded
2008
Website
Employees
10
